Search research articles
Contact Us
Filters
Showing results (211-220 of 224) with videos related to
Page
of 23
Sort By:
European Urology
|
December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials
Todd M Morgan, Yi Ren, Siyi Tang, et al.
JAMA Oncology
|
February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
Felix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2025
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003
Vinai Gondi, Stephanie L Pugh, Minesh P Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2025
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Anson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
Neuro-Oncology
|
May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas
Leeor S Yefet, Alexander P Landry, C Leland Rogers, et al.
European Urology Oncology
|
February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
Neuro-Oncology
|
July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
Andrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
European Urology Oncology
|
April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712
Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
Nature Medicine
|
August 21, 2024
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Justin Z Wang, Vikas Patil, Alexander P Landry, et al.
Cell Reports. Medicine
|
June 21, 2023
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
Markus Bredel, Lluís Espinosa, Hyunsoo Kim, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 224) with videos related to
Sort By:
Page
of 23
European Urology
|
December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials
Todd M Morgan, Yi Ren, Siyi Tang, et al.
JAMA Oncology
|
February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
Felix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2025
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003
Vinai Gondi, Stephanie L Pugh, Minesh P Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2025
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Anson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
Neuro-Oncology
|
May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas
Leeor S Yefet, Alexander P Landry, C Leland Rogers, et al.
European Urology Oncology
|
February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
Neuro-Oncology
|
July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
Andrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
European Urology Oncology
|
April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712
Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
Nature Medicine
|
August 21, 2024
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Justin Z Wang, Vikas Patil, Alexander P Landry, et al.
Cell Reports. Medicine
|
June 21, 2023
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
Markus Bredel, Lluís Espinosa, Hyunsoo Kim, et al.
Page
of 23